Acquiring Company
Viatris
Acquired Company
Capra Biosciences, Inc
PittsburghCaliforniaBiotechnologyHealth CareMedical DeviceDescription
Viatris announced that its subsidiary Peach Purchaser Sub Inc. has commenced a tender offer for all outstanding shares of Pacira BioSciences at $36.50 per share in cash. The offer is governed by a merger agreement dated Oct. 8, 2026, and will expire at 11:59 p.m. Eastern Time on Nov. 16, 2026, unless extended. Pacira's board has unanimously recommended that stockholders accept the offer.
Who to call at Viatris, and when
When Viatris changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Viatris raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Viatris, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Viatris. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Viatris makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Capra Biosciences, Inc?
Capra Biosciences, Inc was acquired by Viatris, based in Pittsburgh. The deal was reported on October 30, 2026. Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania. Viatris is publicly traded (VTRS).
When did Viatris acquire Capra Biosciences, Inc?
Viatris's acquisition of Capra Biosciences, Inc was reported on October 30, 2026. Viatris announced that its subsidiary Peach Purchaser Sub Inc. has commenced a tender offer for all outstanding shares of Pacira BioSciences at $36.50 per share in cash. The offer is governed by a merger agreement dated Oct. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Capra Biosciences, Inc do?
Pacira CryoTech, Inc. is a wholly owned subsidiary of Pacira Biosciences, Inc. that specializes in handheld cryoanalgesia devices and related products. The company is known for its flagship device, iovera®°, which provides non-opioid pain management solutions. It is privately held, operating in Biotechnology, and is based in California.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.